Nasu-Hakola disease, also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, is a rare inherited neuropsychiatric disorder which in addition to cognitive impairment also demonstrates bone cysts.
Although the exact incidence is not known, the condition is considered to be very rare.
Nasu-Hakola disease is often unrecognised until neuropsychiatric symptoms become apparent, which is typically in early middle age (25-40 years of age) 3. Prior to cognitive decline, patients may have a history of bone cysts and fractures. Later a progressive dementia becomes evident, usually characterized by frontal lobe dysfunction (e.g. disinhibition) as well as myoclonic twitches, gait disturbances and seizures 1.
Nasu-Hakola disease is inherited as an autosomal recessive disorder. Two genes have been identified, each able to result in the Nasu-Hakola disease phenotype: TYROBP and TREM2 genes 1.
Imaging features are non-specific. Generalized cerebral atrophy with ex-vacuo dilatation of the ventricles and sulci is usually present, which progresses with the disease. This is associated with high T2 signal in the subcortical and deep white matter 3.
Some patients also demonstrate cerebellar volume loss 3.
Treatment and prognosis
Currently, no specific therapeutic options exist, with management being targeted at dominant clinical symptoms.
Progressive dementia usually results in death in the 5th decade of life 2,3.
History and etymology
The condition was first described separately by T Nasu and H P Hakola in the 1970s 4,5.
- 1. Yamazaki K, Yoshino Y, Mori Y et-al. A Case of Nasu-Hakola Disease without Fractures or Consanguinity Diagnosed Using Exome Sequencing and Treated with Sodium Valproate. Clin Psychopharmacol Neurosci. 2015;13 (3): 324-6. doi:10.9758/cpn.2015.13.3.324 - Free text at pubmed - Pubmed citation
- 2. Bianchin MM, Capella HM, Chaves DL et-al. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy-PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell. Mol. Neurobiol. 2004;24 (1): 1-24. Pubmed citation
- 3. Paloneva J, Autti T, Raininko R et-al. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology. 2001;56 (11): 1552-8. Pubmed citation
- 4. Hakola HP, Järvi OH, Sourander P. Osteodysplasia polycystica hereditaria combined with sclerosing leucoencephalopathy, a new entity of the dementia praesenilis group. (1970) Acta neurologica Scandinavica. doi: - Pubmed
- 5. Nasu T, Tsukahara Y, Terayama K. A lipid metabolic disease-"membranous lipodystrophy"-an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. (1973) Acta pathologica japonica. doi:10.1111/j.1440-1827.1973.tb01223.x - Pubmed
Related Radiopaedia articles
White matter disorders
- white matter
- normal myelination
white matter disorders
- anti-MOG associated encephalomyelitis
- Guillain-Barré syndrome (GBS)
- chronic inflammatory demyelinating polyneuropathy (CIDP)
- transverse myelitis
- tumefactive demyelinating lesions
- acute disseminated encephalomyelitis (ADEM)
- acute hemorrhagic encephalomyelitis (AHEM)
- neuromyelitis optica (NMO) (Devic disease)
multiple sclerosis (MS)
McDonald diagnostic criteria for MS (current 2017 revision)
- previous 2016 MAGNIMS consensus
- McDonald diagnostic criteria for MS (current 2017 revision)
- radiologically isolated syndrome (RIS)
- clinically isolated syndrome (CIS)
- early-onset neuronal degenerative disorders
- giant axonal neuropathy
- hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)
- hypomyelination with congenital cataract
- leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
- hypomyelination with brainstem and spinal cord involvement and leg spasticity
- pol III-related leukodystrophies
- myelin disorders
- myelin vacuolisation
- adult-onset autosomal dominant leukodystrophy
- cerebrotendinous xanthomathosis
- cystic leukoencephalopathy without megalencephaly
- L-2-hydroxyglutaric aciduria
- lysosomal storage diseases
- peroxisomal disorders
- Sjögren-Larsson syndrome